BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17005805)

  • 1. Effect of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, on experimental Chlamydophila pneumoniae infection.
    Caronzolo D; Lucini V; Pannacci M; Grosso S; Kieffer N; Bello L; Bikfalvi A; Scaglione F
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3277-82. PubMed ID: 17005805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.
    Rothstein NM; Quinn TC; Madico G; Gaydos CA; Lowenstein CJ
    J Infect Dis; 2001 Jan; 183(2):232-238. PubMed ID: 11120929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae.
    Caronzolo D; Lucini V; Pannacci M; Grosso S; Colleoni F; Fraschini F; Scaglione F
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4878-81. PubMed ID: 15561871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors 2 and 4 do not contribute to clearance of Chlamydophila pneumoniae in mice, but are necessary for the release of monokines.
    Mueller M; Postius S; Thimm JG; Gueinzius K; Muehldorfer I; Hermann C
    Immunobiology; 2004; 209(8):599-608. PubMed ID: 15638128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Chlamydia pneumoniae reinfection accelerates the development of insulin resistance and diabetes in obese C57BL/6 mice.
    Wang C; Gao D; Kaltenboeck B
    J Infect Dis; 2009 Jul; 200(2):279-87. PubMed ID: 19508161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae.
    Blessing E; Campbell LA; Rosenfeld ME; Chesebro B; Kuo CC
    J Antimicrob Chemother; 2005 Jun; 55(6):1037-40. PubMed ID: 15845780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent azithromycin treatment for respiratory symptoms in patients with chronic Chlamydia pneumoniae infection.
    Brandén E; Koyi H; Gnarpe J; Gnarpe H; Tornling G
    Scand J Infect Dis; 2004; 36(11-12):811-6. PubMed ID: 15764166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of Chlamydia pneumoniae infection in cyclosporin A-induced post-transplant gingival overgrowth tissue and evidence for the possibility of persistent infection despite short-term treatment with azithromycin.
    Worm HC; Wirnsberger GH; Mauric A; Holzer H
    Nephrol Dial Transplant; 2004 Jul; 19(7):1890-4. PubMed ID: 15128877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.
    Hillis GS; Pearson CV; Harding SA; Sutherland S; Ludlam CA; Marioni JC; Prescott RJ; Fox KA; Flapan AD
    Am Heart J; 2004 Jul; 148(1):72-9. PubMed ID: 15215794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corn mint (Mentha arvensis) extract diminishes acute Chlamydia pneumoniae infection in vitro and in vivo.
    Salin O; Törmäkangas L; Leinonen M; Saario E; Hagström M; Ketola RA; Saikku P; Vuorela H; Vuorela PM
    J Agric Food Chem; 2011 Dec; 59(24):12836-42. PubMed ID: 22073967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment.
    Gieffers J; Füllgraf H; Jahn J; Klinger M; Dalhoff K; Katus HA; Solbach W; Maass M
    Circulation; 2001 Jan; 103(3):351-6. PubMed ID: 11157684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin inhibits interleukin-6 but not fibrinogen production in hepatocytes infected with cytomegalovirus and chlamydia pneumoniae.
    Bouwman JJ; Visseren FL; Bouter PK; Diepersloot RJ
    J Lab Clin Med; 2004 Jul; 144(1):18-26. PubMed ID: 15252403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin reduces Chlamydia pneumoniae-induced attenuation of eNOS and cGMP production by endothelial cells.
    Bouwman JJ; Visseren FL; Bevers LM; van der Vlist WE; Bouter KP; Diepersloot RJ
    Eur J Clin Invest; 2005 Sep; 35(9):573-82. PubMed ID: 16128864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Choice of antimicrobial drug for infections caused by Chlamydia trachomatis and Chlamydophila pneumoniae].
    Zele-Starcević L; Plecko V; Budimir A; Kalenić S
    Acta Med Croatica; 2004; 58(4):329-33. PubMed ID: 15700690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.
    Vainas T; Stassen FR; Schurink GW; Tordoir JH; Welten RJ; van den Akker LH; Kurvers HA; Bruggeman CA; Kitslaar PJ
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):403-11. PubMed ID: 15749042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an anti-chlamydial antibiotic therapy influence on asthma patients.
    Gryglicka B; Wegrzyn-Szkutnik I; Michnar M; Mazur E; Niedźwiadek J; Milanowski J
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):444-51. PubMed ID: 15315030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy.
    Esposito S; Bosis S; Begliatti E; Droghetti R; Tremolati E; Tagliabue C; Bellasio M; Blasi F; Principi N
    Clin Infect Dis; 2006 Jul; 43(2):206-9. PubMed ID: 16779748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxycycline suppresses Chlamydia pneumoniae induced interferon-gamma responses in peripheral blood mononuclear cells in children with allergic asthma.
    Smith-Norowitz TA; Weaver D; Norowitz YM; Hammerschlag MR; Joks R; Durkin HG; Kohlhoff S
    J Infect Chemother; 2018 Jun; 24(6):470-475. PubMed ID: 29615379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E-deficient mice develop an anti-Chlamydophila pneumoniae T helper 2 response and resist vascular infection.
    Nazzal D; Therville N; Yacoub-Youssef H; Garcia V; Thomsen M; Levade T; Segui B; Benoist H
    J Infect Dis; 2010 Sep; 202(5):782-90. PubMed ID: 20632890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydophila pneumoniae respiratory tract infection aggravates therapy refractory bronchitis or pneumonia in childhood.
    Schmidt SM; Müller CE; Gürtler L; Bruns R; Ballke EH; Wiersbitzky H; Ehlers M; Rose HJ; Wiersbitzky SK
    Klin Padiatr; 2005; 217(1):9-14. PubMed ID: 15640964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.